Thursday, January 09, 2025 10:16:47 AM
Recent ESPR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2025 09:38:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2025 09:37:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/17/2025 08:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/17/2025 08:17:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2025 01:40:37 PM
- Esperion to Host Virtual Key Opinion Leader Event on Wednesday, January 22, 2025, at 11:30 a.m. ET. • GlobeNewswire Inc. • 01/09/2025 01:00:00 PM
- Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 09:14:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 09:13:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 09:12:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 12:10:59 PM
- Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions • GlobeNewswire Inc. • 12/18/2024 12:00:41 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/17/2024 08:46:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/17/2024 08:22:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/17/2024 08:21:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2024 11:43:14 AM
- Esperion Announces $210 Million Convertible Debt Financing • GlobeNewswire Inc. • 12/13/2024 11:00:00 AM
- Esperion Partners with Neopharm to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Israel • GlobeNewswire Inc. • 12/12/2024 01:00:55 PM
- Esperion Announces New Drug Submissions in Canada for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Treatments to Reduce LDL-C and Cardiovascular Risk • GlobeNewswire Inc. • 12/02/2024 01:00:00 PM
- Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia • GlobeNewswire Inc. • 11/26/2024 01:00:00 PM
- Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/21/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 09:10:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/19/2024 09:07:29 PM
- Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024 • GlobeNewswire Inc. • 11/18/2024 03:30:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 01:42:21 PM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM